GRDN Market Analysis

Overview

Fundamentals

P/E ratio47.91Forward 30.67
EPS (TTM)$0.780.0% YoY
Profit margin3.4%HEALTHCARE
Market cap$2.40BMid cap

Wall Street coverage

$40.83median target· current $16.00 (+155.2%)5 analysts

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

Valuation

Forward P/E
30.67
PEG ratio
P/B
11.69
P/S (TTM)
1.66
EV/EBITDA
24.64

Profitability & growth

ROE (TTM)
26.6%
Operating margin
8.9%
Revenue growth YoY
17.4%
Dividend yield
Beta
Last earnings
Mar 11, 2026 · Estimate $0.27 · Reported $0.37
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Guardian Pharmacy Services, Inc.

Guardian Pharmacy Services, Inc. is a premier provider of specialized pharmacy solutions tailor-made for the long-term care sector, encompassing assisted living and skilled nursing facilities. The company distinguishes itself through a commitment to personalized medication management, rigorous standards of quality and compliance, and exceptional customer service. By leveraging state-of-the-art technology and extensive pharmaceutical expertise, Guardian enhances patient outcomes while optimizing workflows for healthcare partners. With a robust operational footprint across multiple states, the…

Classification

Exchange
NYSE
Country
USA
Currency
USD

Company profile

HQ
300 GALLERIA PARKWAY SE, ATLANTA, GA
Fiscal year end
December
Latest quarter
Dec 31, 2025
Market cap$2.40B
Shares outstanding$37.3M
52W high$41.36
52W low$19.17

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer